Literature DB >> 30073490

Potential Risk Window for Opioid Overdose Related to Treatment with Extended-Release Injectable Naltrexone.

Ingrid A Binswanger1,2,3, Jason M Glanz4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30073490      PMCID： PMC6366853          DOI： 10.1007/s40264-018-0705-8

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  11 in total

1.  Neurochemical and functional correlates of naltrexone-induced opiate receptor up-regulation.

Authors:  A Tempel; E L Gardner; R S Zukin
Journal:  J Pharmacol Exp Ther       Date:  1985-02       Impact factor: 4.030

2.  Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence.

Authors:  Roxanne Saucier; Daniel Wolfe; Nabarun Dasgupta
Journal:  Drug Saf       Date:  2018-10       Impact factor: 5.606

3.  Factors associated with using opiates while under extended-release naltrexone blockade: A descriptive pilot study.

Authors:  Brantley P Jarvis; Anthony DeFulio; Lauren Long; August F Holtyn; Annie Umbricht; Michael Fingerhood; George E Bigelow; Kenneth Silverman
Journal:  J Subst Abuse Treat       Date:  2016-12-24

4.  Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone.

Authors:  Erin Kelty; Gary Hulse
Journal:  Int J Drug Policy       Date:  2017-06-10

Review 5.  A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice.

Authors:  Shane R Mueller; Alexander Y Walley; Susan L Calcaterra; Jason M Glanz; Ingrid A Binswanger
Journal:  Subst Abus       Date:  2015-03-16       Impact factor: 3.716

Review 6.  Extended-release injectable naltrexone for opioid use disorder: a systematic review.

Authors:  Brantley P Jarvis; August F Holtyn; Shrinidhi Subramaniam; D Andrew Tompkins; Emmanuel A Oga; George E Bigelow; Kenneth Silverman
Journal:  Addiction       Date:  2018-03-24       Impact factor: 6.526

7.  Quantitative immunolocalization of mu opioid receptors: regulation by naltrexone.

Authors:  E M Unterwald; B Anton; T To; H Lam; C J Evans
Journal:  Neuroscience       Date:  1998-08       Impact factor: 3.590

8.  Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis.

Authors:  Jun Ma; Yan-Ping Bao; Ru-Jia Wang; Meng-Fan Su; Mo-Xuan Liu; Jin-Qiao Li; Louisa Degenhardt; Michael Farrell; Frederic C Blow; Mark Ilgen; Jie Shi; Lin Lu
Journal:  Mol Psychiatry       Date:  2018-06-22       Impact factor: 15.992

Review 9.  Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.

Authors:  Luis Sordo; Gregorio Barrio; Maria J Bravo; B Iciar Indave; Louisa Degenhardt; Lucas Wiessing; Marica Ferri; Roberto Pastor-Barriuso
Journal:  BMJ       Date:  2017-04-26

10.  Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants - United States, 2015-2016.

Authors:  Puja Seth; Lawrence Scholl; Rose A Rudd; Sarah Bacon
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-03-30       Impact factor: 17.586
View more
  3 in total

Review 1.  The United States opioid epidemic.

Authors:  Jennifer Lyden; Ingrid A Binswanger
Journal:  Semin Perinatol       Date:  2019-01-14       Impact factor: 3.300

Review 2.  Treating Opioid Use Disorder and Related Infectious Diseases in the Criminal Justice System.

Authors:  Daniel Winetsky; Aaron Fox; Ank Nijhawan; Josiah D Rich
Journal:  Infect Dis Clin North Am       Date:  2020-09       Impact factor: 5.982

3.  United States drug courts and opioid agonist therapy: Missing the target of overdose reduction.

Authors:  Joanne Csete
Journal:  Forensic Sci Int Mind Law       Date:  2020-06-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.